Page last updated: 2024-09-05

phosphatidylcholines and Leishmaniasis, Mucocutaneous

phosphatidylcholines has been researched along with Leishmaniasis, Mucocutaneous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adedoyin, A; Anaissie, E; Bernardo, JF; Bolsack, LE; Boyle, A; Branch, RA; DeValeriola, D; DeWit, S; Horwith, G; Kelly, E; Klasterksy, J; Llanos-Cuentas, A; Lopez-Berestein, G; Sculier, JP; Swenson, CE1

Trials

1 trial(s) available for phosphatidylcholines and Leishmaniasis, Mucocutaneous

ArticleYear
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Half-Life; HIV Infections; Humans; Kidney Diseases; Leishmaniasis, Mucocutaneous; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Reference Values

1997